New drugs for the treatment of AIDS in Yunnan Province complete clinical trials

Yunnan Province in recent years targeted research and development of a number of new drugs to treat AIDS, somedrughas completed clinical trials, will be declared "new drug certificate" on the marketYunnan Province research and development of anti-AIDS new anti-AIDS chinese medicine "complex three yellow capsules" in the capital medical university Yu'anHospital, the PLA 302Hospital, Beijing DitanHospital, the Chinese Academy ofChinese Medicine andScience sBeijing Guang'anmen Hospital, the Chinese Academy of Medical Sciences Beijing Concord Hospital and other five clinical trial units, according to the GCP (drug clinical trial clinical trial management norms)standards
successfully completed clinical trial sand, the results show that the drug has
no effect on the humanAt this point, the drug has basically completed all the research and development work of the new drug, will be in accordance with the relevant requirements to organize information to the State Food Drug
administration to declare the "New Drug Certificate." Anti-AIDS chinese medicine new drug "Saitam" (formerly known as "complex SH") in Thailand to complete the phase III clinical trial research to achieve better results, in accordance with the national "
drug registration management measures" requirements, carried out various pre-clinical research work, has now obtained clinical trial research approval Anti-AIDS Chinese medicine new drug "Chisle capsule" completed all pre-clinical research work, is collating information to prepare to declare "drug clinical trial approval." "Pentemycans", "carbon cocciin", "Flazin", Chinese medicine positive anti-toxic capsules, "DC32" and other preclinical research work is accelerating anti-AIDS new drugs (reprinted from the Economic Reference Journal)